Delivery Order SPE2DX22D0010-SPE2D825FHA71
- Not listed
- The Defense Department's Medical Supply Chain awarded a delivery order valued at $11,234.27 to AmerisourceBergen Drug Corp for Nucynta Tabs 50mg on September 8, 2025, with completion scheduled for September 9, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a...
- The Defense Department's Medical Supply Chain awarded a delivery order valued at $11,315.96 to AmerisourceBergen Drug Corp for Nucynta Tabs 50mg, a pain management pharmaceutical. Issued on August 27, 2025, with an ultimate completion date of August 28, 2025, this firm fixed-price delivery order represents a competitive award with no set-aside designation. The contractor will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency Medical Supply Chain awarded a $6,982.00 delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Nucynta Tabs 50mg, a prescription pain management pharmaceutical. This non-set-aside, firm fixed price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order carries an ultimate...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $12,642.22 for Nucynta Tabs 75mg, a pain management pharmaceutical, by the Defense Logistics Agency's Medical Supply Chain on August 28, 2025, with an ultimate completion date of August 29, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and specifies performance at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Nucynta 50 mg tablets (100 count) with a ceiling value of $1,225.04. This firm fixed-price delivery order, with an ultimate completion date of July 23, 2025, represents a direct fulfillment of pharmaceutical needs through the federal medical supply chain. The contract is not set-aside and was competitively awarded, reflecting AmerisourceBergen's established capability as a...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 16, 2025, for the supply of Nucynta ER Tabs 100mg, a prescription opioid pain management medication. This firm fixed-price delivery order, valued at $9,992.08, represents a competitive award with no set-aside designation and is scheduled for completion by July 17, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $1,899.74 to AmerisourceBergen Drug Corp for the supply of Nucynta ER 150 mg tablets (60-count units) on August 5, 2025, with an ultimate completion date of August 6, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The order represents a child contract action under...
- The Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Nucynta ER Tabs 250mg, a controlled-release pain management pharmaceutical. This firm fixed-price delivery order, valued at $8,619.04 with an ultimate completion date of June 2, 2025, represents a non-competitive award executed under an existing contract vehicle. The place of performance is AmerisourceBergen's corporate office located in Conshohocken,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $4,230.11 for Nucynta Tabs 100mg on August 21, 2025. This firm fixed-price contract, which has no set-aside designation, was funded by the Defense Logistics Agency's Medical Supply Chain and will be performed at the awardee's Conshohocken facility, with an ultimate completion date of August 22, 2025. The delivery order represents a short-duration...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,288.63 on July 25, 2025, for the supply of Nucynta Tabs 50mg under a firm fixed price contract. This non-set-aside award is funded by the Defense Logistics Agency's Medical Supply Chain and is scheduled for completion by July 28, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D825FHA71Delivery Order
The Defense Department's Medical Supply Chain awarded a delivery order valued at $10,441.56 to AmerisourceBergen Drug Corp for Nucynta Tabs 50mg on July 18, 2025, with an ultimate completion date of July 21, 2025. The contract is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a single pharmaceutical procurement under the company's broader relationship with the federal government's medical procurement apparatus. This award is a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with Defense Logistics Agency Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp has established itself as a critical vendor for federal medical procurement through open competition, fulfilling pharmaceutical needs across multiple therapeutic domains for military and veteran healthcare systems, the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.4k | 7/18/25 |